Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Evelo Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 66 | 68 | +2 |
| Shares | 47.8M | 47.6M | −230.6K (−0.5%) |
| Value | $290.1M | $161.1M | −$129.0M (−44.5%) |
New holders (10)
Institutions that held Evelo Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 202,754 | $687.0K | 0.00% |
| Gsa Capital Partners LLP | 72,871 | $247.0K | 0.03% |
| Occudo Quantitative Strategies LP | 26,222 | $89.0K | 0.01% |
| D. E. Shaw & Co., Inc. | 22,935 | $78.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 19,800 | $67.0K | 0.00% |
| Walleye Capital LLC | 11,180 | $38.0K | 0.00% |
| Amalgamated Bank | 4,945 | $17.0K | 0.00% |
| Amalgamated Financial Corp. | 4,945 | $17.0K | 0.00% |
| Nisa Investment Advisors, LLC | 2,600 | $9.00K | 0.00% |
| Fairfield Financial Advisors, LTD | 1,075 | $3.64K | 0.00% |
Sold out (8)
Institutions that held Evelo Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Artal Group S.A. | 1,000,000 | $6.07M |
| Alberta Investment Management Corp | 40,000 | $243.0K |
| Vontobel Holding Ltd. | 17,762 | $108.0K |
| Manufacturers Life Insurance Company, The | 16,488 | $100.0K |
| Alpine Global Management, LLC | 14,194 | $86.0K |
| UBS Group AG | 12,588 | $76.0K |
| Advisor Group Holdings, Inc. | 750 | $5.00K |
| Signaturefd, LLC | 78 | $0 |